FOLH1 and prostate cancer: For example, Eiber and colleagues from the Technical University of Munich recently demonstrated that simultaneous 68Ga-PSMA PET/MRI improved localization of primary prostate cancer within the gland of 53 patients when compared to multiparametric MRI alone (areas under the ROC curves: 0.88 vs. 0.73, p < 0.001) (Eiber et al., 2016).